Headline
The latest stories from AHA Today.
Hospitals have treated at least 15 patients in Arizona and New Mexico for methanol poisoning associated with alcohol-based hand sanitizers, according to a report released by the Centers for Disease Control and Prevention. Six of the patients developed seizures, four died and three were discharged…
The National Institutes of Health announced the Medical Imaging and Data Resource Center, a public-private initiative that will create medical imaging tools to detect and personalize therapies for COVID-19 patients.
The National Institute of Allergy and Infectious Diseases has launched a clinical trial to evaluate a potential COVID-19 treatment regimen for hospitalized patients that combines remdesivir with interferon beta-1a, a medication approved to treat multiple sclerosis that laboratory studies suggest…
AHA’s Advancing Health podcast channel recently ranked 7th on Feedspot’s Top 55 Healthcare Leadership Podcasts To Follow in 2020.
Michael Schmidt, researcher at the Medical University of South Carolina and co-director of Environmental & Health Crimes at the National Mass Violence Victimization Resource Center, unveils a new partnership between his organization and AHA’s Hospitals Against Violence initiative, which is…
More than one in four individuals in a recent national survey reported they would wait four months or longer to seek previously skipped medical care due to fear of COVID-19.
The Centers for Medicare & Medicaid Services and Department of the Treasury approved a Section 1332 waiver for New Hampshire to implement a five-year reinsurance program for its individual health insurance market beginning in 2021.
Missouri voters approved an expansion of the state’s Medicaid initiative, the second state to do so during the COVID-19 pandemic.
Health care facilities or providers facing inadequate supplies of certain drugs needed to treat patients with COVID-19 should not use the products more than four hours beyond the labeled “in-use time” for refrigerated storage or two hours beyond the labeled “in-use time” for room temperature…
The departments of Health and Human Services and Defense will pay Janssen Pharmaceutical Companies of Johnson & Johnson $1 billion to manufacture 100 million doses of its COVID-19 vaccine candidate for use in clinical trials, or to vaccinate Americans if authorized by the Food and Drug…